Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Surgical Oncology|June 28, 2018
The ypT category does not impact overall survival in node negative gastric cancerNaruhiko Ikoma, Wayne L Hofstetter, Jeannelyn S Estrella, et al.
The Journal of Surgical Research|July 13, 2013
A focused curriculum in surgical oncology for the third-year medical studentsWilliam R Wisniewski, Keith F Fournier, Yan K Ling, et al.
Journal of Surgical Oncology|July 7, 2012
Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtypeCary Hsu, Asif Rashid, Yan Xing, et al.
Annals of Surgical Oncology|September 27, 2025
Repeat Cytoreductive Surgery for Colorectal Cancer Metastatic to the Peritoneal CavityPaula Marincola Smith, Jessica J Lie, Ashlee Seldomridge, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinomaIchiaki Ito, Abdelrahman Mg Yousef, Princess N Dickson, et al.
Annals of Surgical Oncology|February 1, 2018
Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 TrialAndrea A Hayes-Jordan, Brian A Coakley, Holly L Green, et al.
Annals of Surgical Oncology|March 21, 2022
What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers?Abhineet Uppal, Beth Helmink, Travis E Grotz, et al.
The American Journal of Surgical Pathology|August 10, 2020
Malignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 CasesAnais Malpica, Elizabeth D Euscher, Mario L Marques-Piubelli, et al.
Cancer Research|July 11, 2023
Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal AdenocarcinomaIchiaki Ito, Abdelrahman M G Yousef, Saikat Chowdhury, et al.
Annals of Surgical Oncology|July 12, 2017
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient SelectionTravis E Grotz, Michael J Overman, Cathy Eng, et al.
Pageof 6